Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

40
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
40

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Optimizing Clinical Study Designs for CAR-T Cell Therapy: Development of an Efficient Sampling Strategy Through Optimal Experimental Design.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Advancing quantitative clinical pharmacology competencies in Francophone Africa through an on-line learning framework.

Journal of pharmacokinetics and pharmacodynamics·2026
Same author

Breaking Barriers Between Species: Integrated Multi-Species PK Models Improve Human PK Predictions.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Innovative Clinical Trial Approach for Evaluating Digital Medical Devices Under European Fast-Track Regulatory Frameworks.

Statistics in medicine·2026
Same author

Review of Existing Approaches and Potential Role of Pharmacometrics in the Interpretation of Prognostic Circulating Serum Biomarkers in Advanced NSCLC.

Clinical and translational science·2026
Same author

Novel Drug-Disease Modeling Framework for Oncology Benefit-Risk Evaluation: Application to Tusamitamab Ravtansine.

CPT: pharmacometrics & systems pharmacology·2026

相关实验视频

Updated: Jul 1, 2025

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
09:35

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

17.8K

多源数据整合的贝叶斯框架-从临床前研究中对人体推断的应用.

Sandrine Boulet1,2, Moreno Ursino1,2,3, Robin Michelet4

  • 1Inria, HeKA, Paris, France.

Statistical methods in medical research
|March 6, 2024
PubMed
概括
此摘要是机器生成的。

这项研究引入了贝叶斯框架来整合临床前药物数据,改善了人类剂量预测. 该方法提高了数据利用率,减少了不确定性,并支持更有效的临床试验剂量选择.

关键词:
可比性可比性是指可比性.赫林格尔距离距离的距离之后的冲突冲突.后来的合并后的合并.翻译工作的翻译工作.

更多相关视频

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.4K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K

相关实验视频

Last Updated: Jul 1, 2025

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
09:35

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

17.8K
A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.4K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K

科学领域:

  • 药理学和毒理学 药理学和毒理学
  • 生物统计学和数据科学

背景情况:

  • 临床前药物研究 (体外,体内,体内) 评估药物动力学,药物动力学和毒理学概况.
  • 目前的方法往往独立分析临床前研究,限制了人类剂量预测的知识整合.

研究的目的:

  • 提出一个可定制的贝叶斯框架,用于多源临床前数据集成.
  • 通过利用所有可用的临床前信息来提高人类剂量范围预测的精度和可靠性.

主要方法:

  • 一个四步的方法,涉及顺序参数估计,人体推算,后部分布可比性检查和信息合并.
  • 使用贝叶斯推理来实现多源数据集成.
  • 通过基于瘤学实例的广泛模拟进行评估.

主要成果:

  • 建议的贝叶斯框架有效地整合了各种临床前数据来源.
  • 与标准框架相比,证明了预测不确定性的减少.
  • 对更有效,更可靠地选择人类药物剂量的潜力.

结论:

  • 开发的贝叶斯框架为药物开发中利用临床前数据提供了一种优越的方法.
  • 这种方法可以导致更知情和精确的早期临床剂量选择.
  • 提高了人类试验临床前研究的预测能力.